2020 Help me understand this report
Pentosan Polysulfate–Associated Macular Disease in Patients With Interstitial Cystitis
Abstract: (Abstracted from Obstet Gynecol 2020;135:1091–1094) As the approved oral agent for interstitial cystitis, pentosan polysulfate sodium (PPS) has been widely used since its approval in 1996. Historically recognized adverse effects of PPS are not serious.
This publication either has no citations yet, or we are still processing them
Set email alert for when this publication receives citations?
See others like this or search for similar articles
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
